https://www.selleckchem.com/pr....oducts/Gefitinib.htm
AIMS To evaluate the clinical utility of first and second trimester prenatal screening biomarkers for early pregnancy prediction of gestational diabetes mellitus (GDM) risk in nulliparous women METHODS We conducted a population-based cohort study of nulliparous women participating in the California Prenatal Screening Program from 2009-2011 (n=105,379). GDM was ascertained from hospital discharge records or birth certificates. Models including maternal characteristics and prenatal screening biomarkers were developed and validated. Risk
Like
Comment
Share
